Previous close | 2.0800 |
Open | 3.0020 |
Bid | 3.5910 x 0 |
Ask | 3.6280 x 0 |
Day's range | 3.0020 - 3.0020 |
52-week range | 1.3700 - 9.8100 |
Volume | |
Avg. volume | 22 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Emergent BioSolutions Inc Earnings Call
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone. I’m […]
Emergent BioSolutions Inc (EBS) showcases robust revenue growth and operational efficiency in the first quarter of 2024.